iRhythm Technologies Inc (IRTC)
73.99
+0.09
(+0.12%)
USD |
NASDAQ |
Nov 22, 16:00
73.88
-0.10
(-0.14%)
After-Hours: 20:00
iRhythm Technologies Gross Profit Margin (Quarterly): 68.78% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 68.78% |
| June 30, 2024 | 69.89% |
| March 31, 2024 | 66.34% |
| December 31, 2023 | 65.98% |
| September 30, 2023 | 66.19% |
| June 30, 2023 | 69.46% |
| March 31, 2023 | 67.91% |
| December 31, 2022 | 69.89% |
| September 30, 2022 | 68.28% |
| June 30, 2022 | 68.83% |
| March 31, 2022 | 66.85% |
| December 31, 2021 | 62.69% |
| September 30, 2021 | 65.72% |
| June 30, 2021 | 68.02% |
| March 31, 2021 | 68.43% |
| December 31, 2020 | 73.99% |
| September 30, 2020 | 74.66% |
| June 30, 2020 | 69.57% |
| March 31, 2020 | 74.72% |
| Date | Value |
|---|---|
| December 31, 2019 | 76.46% |
| September 30, 2019 | 74.79% |
| June 30, 2019 | 75.19% |
| March 31, 2019 | 75.64% |
| December 31, 2018 | 74.14% |
| September 30, 2018 | 74.11% |
| June 30, 2018 | 73.24% |
| March 31, 2018 | 71.83% |
| December 31, 2017 | 71.53% |
| September 30, 2017 | 72.36% |
| June 30, 2017 | 71.73% |
| March 31, 2017 | 70.44% |
| December 31, 2016 | 69.07% |
| September 30, 2016 | 68.52% |
| June 30, 2016 | 67.23% |
| March 31, 2016 | 63.75% |
| December 31, 2015 | 61.66% |
| September 30, 2015 | 59.89% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
62.69%
Minimum
Dec 2021
76.46%
Maximum
Dec 2019
69.13%
Average
68.61%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 55.83% |
| Boston Scientific Corp | 68.83% |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 58.37% |
| Catheter Precision Inc | 89.58% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -109.0% |
| Return on Assets | -20.86% |
| Return on Invested Capital | -27.94% |
| Profit Margin (Quarterly) | -31.30% |
| Operating Margin (Quarterly) | -33.66% |
| Return on Net Operating Assets | -60.50% |